Kendall E Hansen MD PLC
Kendall E Hansen MD PLC was paid $450K by Medicaid between Jan 2018 and Apr 2022, across 23 billing codes. Its largest line is G0482, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed — 33% of everything it billed.
CRESTVIEW HILLS, KY 41017
Next to other Nurse Practitioner providers in Kentucky
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,582 | $183K | |
| 2019 | 9,547 | $106K | |
| 2020 | 9,134 | $85K | |
| 2021 | 6,890 | $73K | |
| 2022 | 67 | $2K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 33% | 2,511 | 2,153 | $150K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33% | 11,869 | 8,534 | $148K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 14% | 3,083 | 2,712 | $63K |
| 99152 | 4.1% | 4,918 | 3,484 | $18K | |
| 27096 | 3.5% | 304 | 214 | $16K | |
| 64635 | 2.8% | 198 | 143 | $13K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.1% | 1,563 | 1,033 | $9K |
| 64636 | 1.2% | 138 | 91 | $5K | |
| 99441 | 1.1% | 650 | 496 | $5K | |
| 99442 | 1.1% | 308 | 224 | $5K | |
| 64483 | 1.1% | 134 | 97 | $5K | |
| 64493 | <1% | 128 | 82 | $4K |
11 more codes
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 68 | $2K |
| 64494 | <1% | 80 | $2K | |
| J3490 | Unclassified drugs | <1% | 4,954 | $1K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 4,691 | $1K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 486 | $858.61 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 731 | $837.89 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 2,228 | $331.15 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 37 | $249.47 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 15 | $2.52 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 111 | $2.34 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 15 | $0.33 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Crestview Hills Surgery Center, PLLC | Crestview Hills, KY | $66K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.